June 5 (Reuters) – A newly approved immunotherapy from Roche
Holding proved effective as an initial treatment for
some patients with advanced bladder cancer, according to data
presented on Sunday.
The post Roche therapy helps 24 pct of untreated bladder cancer patients-study appeared first on NASDAQ.